160 likes | 345 Views
Dilemma in management of DCIS. Julia Tchou, M.D., Ph.D. Abramson Cancer Center Rena Rowan Breast Center Department of Surgery University of Pennsylvania. The Dilemma of DCIS. 96-98% of women with DCIS are cured with local therapy, yet …
E N D
Dilemma in management of DCIS Julia Tchou, M.D., Ph.D. Abramson Cancer Center Rena Rowan Breast Center Department of Surgery University of Pennsylvania
The Dilemma of DCIS 96-98% of women with DCIS are cured with local therapy, yet … Local recurrence rate after BCT of DCIS is ~ 2 fold higher than Invasive cancer.
Standard Treatment in DCIS •Mastectomy •Excision + RT •Excision + Tamoxifen Which Rx for which patient?
Key questions in management of DCIS • Can we identify a subset of patient not benefiting from radiation therapy? • What is an adequate margin?
Survival in DCIS by Treatment L L+RT B17 L+RT+TAM EORTC M B17; EORTC % Deaths Breast Ca B24 B24 Years
Effects of XRT on survival EBCTCG meta-analsyis, Lancet 2005
Key Management Concepts in DCIS • Prevention of local recurrence (invasive and noninvasive) is a major goal of the treatment of DCIS The use of RT reduces LR in DCIS
Local recurrence risk stratification • ECOG – < 2.5 cm Grade I & II DCIS • EORTC – no subgroup does not benefit from radiation • VNPI - Silverstein Bijker, N. JCO 2006;24:3381
Van Nuys Prognostic Index Silverstein, M 2003
Outcome in DCIS Patients withLow VNPI Low VNPI (3 or 4) Silverstein de Mascarel # patients 101 195 Local recurrence 2% 9% Invasive 0 50% Br Ca Res Treat 2000
Is there a DCIS subgroup that does not benefit from XRT? • Age • Margins (uniform and meticulous assessment not done in randomized trials) • VNPI score 4, 5 or 6 • Low grade DCIS • Biomarkers for risk stratification • Utility of MRI in preoperative assessment (JNCI consensus statement, 2009) Morrow M 2008